July 28, 2010 – This week St. Jude Medical filed a patent infringement lawsuit against Volcano Corp. over its fractional flow reserve (FFR) wires. The suit was filed in federal district court in Delaware. Volcano said the claims against it are entirely without merit.

July 27, 2010 – Two new cardiac stress test systems optimize space to allow testing in a greater variety of settings, offer wireless data acquisition and better electronic medical record (EMR) connectivity.


Heart failure is a progressively debilitating disease that dramatically decreases the life expectancy and quality of life of affected patients. Nearly 5.8 million Americans are diagnosed with heart failure today, according to annual American Heart Association statistics.


July 27, 2010 – Atherosclerotic plaque causes audible turbulence in the bloodstream and a new device can help isolate these sounds to aid in earlier detection of plaque changes.

July 27, 2010 – Results of the largest U.S. outpatient heart failure clinical study show that implementation of a process improvement program significantly improved adherence to evidence-based, guideline-recommended cardiac resynchronization therapy (CRT), implantable cardioverter-defibrillator (ICD) and drug therapy.

July 26, 2010 – Today a fourth-generation intracranial aneurysm stent
system was released in both the U.S. and European markets. Boston Scientific’s Neuroform EZ Stent System is designed for use in conjunction with endovascular coiling to treat wide-necked aneurysms.

July 26, 2010 – The U.S. Food and Drug Administration (FDA) approved the first generic version of Lovenox (enoxaparin sodium injection), an anticoagulant drug used for multiple indications, including prevention of deep vein thrombosis (DVT), a potentially deadly blood clotting condition.

July 26, 2010 – A new three-in-one combination drug has been approved by the U.S. Food and Drug Administration (FDA) for the treatment of hypertension in patients who do not respond to dual medical treatment. Daiichi Sankyo Inc.

July 26, 2010 – The Centers for Medicare and Medicaid Services (CMS) announced it is soliciting proposals for participation in the Medicare Imaging Demonstration (MID).

July 23, 2010 – For patients suffering from a heart attack, every minute counts, yet the average time from start of chest pain to receiving emergency room (ER) medical attention is 3.2 hours. The average turn-around time of lab-based test results is 2.8 hours, with the minimum time to detect a heart attack using today’s lab-based immunodiagnostics is 4.5 hours from symptom outset.

Subscribe Now